Kidney Disease
NKF: Patients with kidney disease should be prioritized for COVID-19 vaccines
The National Kidney Foundation has released a statement urging the federal government to grant priority to patients with kidney disease and their contacts for receipt of COVID-19 vaccines.
Survey: Conservative kidney care available in most countries, but quality varies
Findings from the 2018 Global Kidney Health Atlas survey showed that although conservative management for kidney disease is available in most countries, the quality and accessibility of care varies.
Long-term exposure to air pollution may increase risk for kidney disease
After estimating levels of fine particulate matter air pollution, researchers from China found neighborhoods with more pollution had an increased prevalence of chronic kidney disease and albuminuria.
Relationship of HIV severity, endothelial function may predict additional CVD risk
The relationship between HIV and arterial endothelial function may imply CVD risk among infected patients, particularly if they also have kidney disease, according to a study published in Arteriosclerosis, Thrombosis, and Vascular Biology.
KDIGO places more emphasis on guideline updates, including anemia and diabetes management
Kidney Disease: Improving Global Outcomes is prioritizing its evidence-based guidelines, expanding the guideline development process “to include more frequent and rapid updates,” according to a press release.
Widely available test could identify SARS-CoV-2 antibody in patients with kidney disease
Researchers in the United Kingdom have determined that a widely available test is effective among patients with kidney disease for detection of an antibody that can develop after exposure to SARS-CoV-2.
NKF, RenalytixAI partner to improve kidney disease diagnosis
The National Kidney Foundation has formed a partnership with RenalytixAI to improve kidney disease diagnosis and assessment in early stages of the disease.
Should physicians reconsider the use of race correction in clinical algorithms?
Yes, clinicians should consider other important variables apart from race.
American Kidney Fund to host virtual event on inaccurate diagnoses of kidney disease
The American Kidney Fund announced it is hosting a virtual event in which experts will discuss how “undiagnosed or misdiagnosed causes of kidney disease” may impact patients.
Ertugliflozin HF benefits differ based on kidney disease severity
The HF benefits observed in adults with type 2 diabetes and atherosclerotic CVD treated with the SGLT2 inhibitor ertugliflozin were greater among those with moderate to high risk for kidney disease.